共 49 条
- [41] Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02): : 657 - 657
- [42] Baseline values and early (6-month) changes in total and bone specific alkaline phosphatase do not predict long-term (4-year) bone mineral density changes in postmenopausal osteoporotic women treated with fluoride. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S199 - S199
- [45] Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: A three-year, double-blind, placebo-controlled, randomized clinical trial JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05): : 2762 - 2767
- [49] Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial Osteoporosis International, 2021, 32 : 1441 - 1449